Tools & Calculators
Sector: Pharmaceuticals & Biotechnology
|Mid Cap
Aarti Pharmalabs Ltd.
₹632.60
Invest in AARTIPHARM with up to 2.50x margin.
Trade with MTF₹610.00
₹654.80
₹574.45
₹971.00
Markets Today
Historical Performance
Indicator | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|---|---|
| Total Revenue | 425.25 | 417.29 | 375.31 | 529.62 | 470.95 |
| Operating Expense | 322.31 | 343.31 | 280.18 | 386.50 | 355.96 |
| Operating Profit | 102.94 | 73.98 | 95.13 | 143.13 | 114.99 |
| Depreciation | 28.62 | 24.77 | 22.76 | 20.83 | 21.04 |
| Interest | 12.58 | 10.66 | 6.79 | 6.29 | 9.70 |
| Tax | 14.74 | 10.77 | 15.95 | 24.66 | 22.66 |
| Net Profit | 43.84 | 30.93 | 51.22 | 88.85 | 73.52 |
Research Type
Equity , Long Term
Buy Range
₹733 - ₹751
Target Price
₹868
Stop Loss
-
Target Date
14 Sep 26
Potential Returns
18.42 %
₹632.60
↗ Bullish Moving Average
0
↘ Bearish Moving Average
16
| Held By | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 |
|---|---|---|---|---|---|---|
| Promoter | 46.1 | 44.7 | 44.3 | 43.7 | 42.9 | 43.1 |
| FII | 7.4 | 8.6 | 7.4 | 7.3 | 8 | 7.7 |
| DII | 11.3 | 10.4 | 7.5 | 7.9 | 7 | 7.7 |
| Public | 35.2 | 36.3 | 40.8 | 41.1 | 42.1 | 41.5 |
| Period | Combined Delivery Volume | NSE+BSE Traded Volume Avg | Daily Avg Delivery Volume % |
|---|---|---|---|
| Day | 2.97 L | 5.48 L | 54.13% |
| Week | 2.15 L | 4.05 L | 53.10% |
| 1 Month | 1.2 L | 2.32 L | 51.80% |
| 6 Month | 1.03 L | 2.19 L | 47.30% |
Benjamin Graham Value Screen
PEG lower than Industry PEG
Growth in Net Profit with increasing Profit Margin (QoQ)
Companies with Low Debt
Increasing Revenue every quarter for the past 2 quarters
Annual Net Profits improving for last 2 years
Book Value per share Improving for last 2 years
Volume Shockers
Ex-Date | Dividend Amount | Dividend Type | Record Date | Instrument Type |
|---|---|---|---|---|
| 16 Feb, 2026 | 1.5 | INTERIM | 16 Feb, 2026 | Equity Share |
| 15 Sep, 2025 | 2.5 | FINAL | 15 Sep, 2025 | Equity Share |
| 14 Feb, 2025 | 2.5 | INTERIM | 14 Feb, 2025 | Equity Share |
| 31 Jul, 2024 | 1 | FINAL | 31 Jul, 2024 | Equity Share |
| 16 Feb, 2024 | 2 | INTERIM | 19 Feb, 2024 | Equity Share |
Financials | ||||||
|---|---|---|---|---|---|---|
| Price (₹) | ₹1,550 | ₹612.35 | ₹780.95 | ₹1,444.80 | ₹4,532.50 | ₹495.55 |
| % Change | -0.39% | 3.34% | 1.05% | -1.93% | 5.45% | 6.32% |
| Revenue TTM (₹ Cr) | - | - | ₹1,598.19 | ₹1,419.33 | ₹878.40 | ₹4,256.70 |
| Net Profit TTM (₹ Cr) | - | - | ₹206.20 | ₹20.10 | ₹240.10 | ₹318.19 |
| PE TTM | - | - | 61.70 | 840.10 | 41.20 | 23.10 |
| 1 Year Return | 46.52 | -0.08 | 59.34 | -15.92 | -10.95 | -1.5 |
| ROCE | 30.24 | 34.78 | 34.76 | 3.26 | - | 11.27 |
Blue Jet Healthcare Ltd
₹ 350.95
+7.24%
Concord Biotech Ltd.
₹ 1020.00
+0.16%
Piramal Pharma Ltd.
₹ 142.65
+4.47%
Acutaas Chemicals Ltd.
₹ 2346.10
-8.31%
Alivus Life Sciences Ltd.
₹ 982.15
+0.97%
Cohance Lifesciences Ltd.
₹ 312.15
+3.55%
Eris Lifesciences Ltd.
₹ 1307.70
+0.81%
Syngene International Ltd.
₹ 395.80
+1.51%
Alembic Pharmaceuticals Ltd.
₹ 674.10
+1.64%
Strides Pharma Science Ltd.
₹ 964.95
+2.90%
Granules India Ltd.
₹ 628.90
+1.37%
Wockhardt Ltd.
₹ 1269.10
+7.94%
FDC Ltd.
₹ 328.35
+2.26%
Shilpa Medicare Ltd.
₹ 374.55
+7.35%
Jubilant Pharmova Ltd.
₹ 816.65
+0.02%
Natco Pharma Ltd.
₹ 1002.55
+2.91%
Caplin Point Laboratories Ltd.
₹ 1576.10
+4.74%
Neuland Laboratories Ltd.
₹ 12596.00
+4.73%
Marksans Pharma Ltd.
₹ 168.31
+7.28%
Sanofi India Ltd.
₹ 3268.50
+1.83%
Procter & Gamble Health Ltd.
₹ 4812.80
+0.29%
Jeena Sikho Lifecare Ltd.
₹ 589.70
+9.26%
By signing up I certify terms, conditions & privacy policy